Seeking Alpha

VNDA
Vanda Pharmaceuticals Inc. - NASDAQ

4/16/2014, 3:24 AM ET
Quote & Analysis Breaking News StockTalk
vnda chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 2 articles on this stock available only to PRO subscribers.
Other Articles
VNDA vs. ETF Alternatives
Company Description

Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.

Sector: Healthcare
Industry: Biotechnology
Country: United States